Chong Kun Dang Pharmaceutical Corp. (KRX:185750)

South Korea · Delayed Price · Currency is KRW

81,500

-10,000 (-10.93%)

At close: Mar 4, 2026

Revenue by Segment

Financials in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016
Medical Supply Manufacturing Business	1.59T	1.67T	1.49T	1.34T	1.30T
Medical Supply Manufacturing Business Growth	-4.97%	12.17%	10.78%	3.11%	20.72%
Total	1.59T	1.67T	1.49T	1.34T	1.30T
Total Growth	-4.97%	12.17%	10.78%	3.11%	20.72%

Revenue by Geography

Financials in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016
South Korea	1.51T	1.49T	1.42T	1.29T	1.25T
South Korea Growth	1.28%	4.91%	10.67%	2.88%	21.22%
Japan	38.20B	41.16B	45.89B	43.91B	42.00B
Japan Growth	-7.19%	-10.32%	4.51%	4.55%	7.37%
Others	16.78B	133.98B	19.21B	7.34B	10.92B
Others Growth	-87.48%	597.51%	161.70%	-32.78%	34.53%
Algeria	19.24B	1.19B	-	6.25B	-
Algeria Growth	1511.44%	-	-	-	-
Total	1.59T	1.67T	1.49T	1.34T	1.30T
Total Growth	-4.97%	12.17%	10.78%	3.11%	20.72%

Source: S&P Global Market Intelligence.